Clinical Trials
20 trialsNCT07628751 2026-06-05
SOCRATES HCC
University Health Network, Toronto
Phase NA Recruiting
NCT07621406 2026-06-02
Efficacy and Safety of Sequential Autologous Hematopoietic Stem Cell Transplantation Combined With Tafasitamab, Lenalidomide, and Standard Immunochemotherapy for Relapsed/Refractory Diffuse Large B-cell Lymphoma
The First Affiliated Hospital of Soochow University
Phase 2 Active not recruiting
NCT07474090 2026-06-01
STEPS-BC
Wake Forest University Health Sciences
Phase NA Active not recruiting
NCT07336238 2026-05-29
Group Retreat Psilocybin Therapy for the Treatment of Anxiety and Depression in Patients With Metastatic Solid Tumors or Incurable Hematologic Malignancies
University of Washington
Phase 2 Recruiting
NCT03089554 2026-05-27
Evaluating Genomic Testing in Human Cancer & Outcomes of Targeted Therapies
University of Kentucky
Phase 2 Recruiting
NCT06582784 2026-05-22
IMPACT
Medical University of South Carolina
Phase NA Recruiting
NCT03610022 2026-05-19
OPTIVISMO-1
University Hospital, Bordeaux
Phase 4 Completed
NCT07117630 2026-05-19
An Open-Label, Bayesian Adaptive Phase II Clinical Study in HR+/HER2- Advanced Breast Cancer After Progression on Standard Therapy
Fudan University
Phase 2 Recruiting
NCT07570589 2026-05-11
REAL MG PRO
Centre Hospitalier Universitaire de Nice
Not yet recruiting
NCT07301424 2026-05-06
Subcutaneous Blinatumomab Plus Ponatinib for BCR-ABL+ B-ALL
University of Alberta
Phase 2 Not yet recruiting
NCT07524894 2026-05-01
SNIFF
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Phase 2 Not yet recruiting
NCT07024329 2026-04-30
RESPONd
University of Calgary
Phase NA Recruiting
NCT07555756 2026-04-29
An International Multicenter Clinical Study on Application of UroMed AI Doctor Based on Large Language Models
First Affiliated Hospital of Guangxi Medical University
Phase NA Not yet recruiting
NCT05509751 2026-04-28
SOAR
University of Toronto
Phase NA Active not recruiting
NCT07542717 2026-04-21
ASCERV Study: MRG003 Combined With QL1706 in Recurrent or Metastatic Cervical Cancer
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase 1/2 Not yet recruiting
NCT06492759 2026-04-17
High Dose Radiation Therapy With Pembrolizumab and Chemotherapy for the Treatment of Patients With PD-L1 Positive Metastatic Triple Negative Breast Cancer
Emory University
Phase 2 Recruiting
NCT07530224 2026-04-15
JAK Inhibitors for Solid Malignant Tumor Patients With Refractory Immune Checkpoint Inhibitors-related Dermatitis
Hangzhou Cancer Hospital
Phase 2 Not yet recruiting
NCT07526597 2026-04-13
STOP-CLL-DCT
UNC Lineberger Comprehensive Cancer Center
Phase 2 Not yet recruiting
NCT05601206 2026-04-09
CARES-Lite
University of Pittsburgh
Phase NA Not yet recruiting
NCT06708754 2026-03-30
PBM-LEF
NYU Langone Health
Phase NA Recruiting